You just read:

Acceptance of NDA for Review, Acquisitions of Development Rights, Earnings Release Schedulesm and New Leaders - Research Report on Gilead, Lilly, Allergan, Incyte, and Varian Medical Systems

News provided by

Analysts' Corner

Jan 16, 2014, 08:00 EST